Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Pancreas
|
September 16, 2023
Successful Development of a Natural Language Processing Algorithm for Pancreatic Neoplasms and Associated Histologic Features
Jon Michael Harrison, Adam Yala, Peter Mikhael, et al.
Journal for Immunotherapy of Cancer
|
December 4, 2025
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy
Giovanna Polcaro, Luigi Liguori, Valentina Manzo, et al.
Annals of Surgery
|
March 14, 2017
Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study
Christina H Shin, Dustin R Long, Duncan McLean, et al.
Cancer Letters
|
September 3, 2017
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram
Juan Cong, Yangyang Wang, Xiao Zhang, et al.
The British Journal of Surgery
|
June 1, 2023
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy
Laura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
European Radiology
|
October 19, 2021
Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy
Yoshifumi Noda, Nisanard Pisuchpen, Nathaniel D Mercaldo, et al.
Surgery
|
February 16, 2024
Clinical and pathological factors associated with survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy: A retrospective multi-institutional analysis
Takayuki Shimizu, Shimpei Maeda, Jason Link, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 30, 2022
Programmed death-ligand 1 expression in the immune compartment of colon carcinoma
Osman Yılmaz, Amaya Pankaj, Azfar Neyez, et al.
Neoplasia (New York, N.Y.)
|
February 25, 2014
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker
Giuseppe Sconocchia, Serenella Eppenberger-Castori, Inti Zlobec, et al.
Journal of Clinical Medicine
|
June 19, 2024
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers
Luigi Asmundo, Francesco Rizzetto, Michael Blake, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Pancreas
|
September 16, 2023
Successful Development of a Natural Language Processing Algorithm for Pancreatic Neoplasms and Associated Histologic Features
Jon Michael Harrison, Adam Yala, Peter Mikhael, et al.
Journal for Immunotherapy of Cancer
|
December 4, 2025
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy
Giovanna Polcaro, Luigi Liguori, Valentina Manzo, et al.
Annals of Surgery
|
March 14, 2017
Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study
Christina H Shin, Dustin R Long, Duncan McLean, et al.
Cancer Letters
|
September 3, 2017
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram
Juan Cong, Yangyang Wang, Xiao Zhang, et al.
The British Journal of Surgery
|
June 1, 2023
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy
Laura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
European Radiology
|
October 19, 2021
Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy
Yoshifumi Noda, Nisanard Pisuchpen, Nathaniel D Mercaldo, et al.
Surgery
|
February 16, 2024
Clinical and pathological factors associated with survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy: A retrospective multi-institutional analysis
Takayuki Shimizu, Shimpei Maeda, Jason Link, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 30, 2022
Programmed death-ligand 1 expression in the immune compartment of colon carcinoma
Osman Yılmaz, Amaya Pankaj, Azfar Neyez, et al.
Neoplasia (New York, N.Y.)
|
February 25, 2014
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker
Giuseppe Sconocchia, Serenella Eppenberger-Castori, Inti Zlobec, et al.
Journal of Clinical Medicine
|
June 19, 2024
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers
Luigi Asmundo, Francesco Rizzetto, Michael Blake, et al.
Page
of 5